Down-regulation of bcr-abl and bcl-xL expression in a leukemia cell line and its doxorubicin-resistant variant by topoisomerase II inhibitors
- 30 November 2000
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 60 (12) , 1823-1828
- https://doi.org/10.1016/s0006-2952(00)00497-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Transcriptional down-regulation of c-myc expression in an erythroleukemic cell line, K562, and its doxorubicin-resistant variant by two topoisomerase II inhibitors, doxorubicin and amsacrineAnti-Cancer Drugs, 1998
- Bcr-abl translocation can occur during the induction of multidrug resistance and confers apoptosis resistance on myeloid leukemic cell linesCell Death & Differentiation, 1997
- Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death MachineryCell, 1997
- Structure and function of type II DNA topoisomerasesBiochemical Journal, 1994
- High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapyBlood, 1993
- Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicinNucleic Acids Research, 1990
- Characterization of the topoisomerase II-induced cleavage sites in the c-myc proto-oncogeneBiochemical Pharmacology, 1986
- Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosomeBlood, 1975
- Ribonucleic acid isolated by cesium chloride centrifugationBiochemistry, 1974
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970